Hiroki Shimizu
Papers
1
Total Citations
3
H-Index
1
About
Dr. Hiroki Shimizu is a surgical oncologist whose research focuses on the perioperative management and risk stratification of patients undergoing gastric cancer surgery. His most-cited work, a 2024 study on risk factors for postoperative liver dysfunction, has already garnered 3 citations, underscoring its immediate clinical relevance. In this pivotal study, Dr. Shimizu and his team retrospectively analyzed data to identify key predictors of hepatobiliary enzyme abnormalities following gastrectomy, demonstrating that such liver dysfunction is not merely a transient lab finding but a significant factor impacting patient recovery and long-term outcomes. By elucidating these risk factors, his research provides surgeons with actionable insights to anticipate complications, tailor postoperative monitoring, and improve overall surgical safety. Dr. Shimizu’s contributions are particularly valuable in the context of gastric cancer, where surgical morbidity remains a critical challenge. His work bridges a gap in understanding the interplay between surgical technique and hepatic physiology, offering a foundation for future prospective trials aimed at reducing postoperative liver injury and enhancing patient quality of life.
Research Focus
Key Achievements
Top Papers
- 1